These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 19208844)

  • 1. RECK negatively regulates matrix metalloproteinase-9 transcription.
    Takagi S; Simizu S; Osada H
    Cancer Res; 2009 Feb; 69(4):1502-8. PubMed ID: 19208844
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The membrane-anchored matrix metalloproteinase (MMP) regulator RECK in combination with MMP-9 serves as an informative prognostic indicator for colorectal cancer.
    Takeuchi T; Hisanaga M; Nagao M; Ikeda N; Fujii H; Koyama F; Mukogawa T; Matsumoto H; Kondo S; Takahashi C; Noda M; Nakajima Y
    Clin Cancer Res; 2004 Aug; 10(16):5572-9. PubMed ID: 15328199
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion.
    Liu LT; Chang HC; Chiang LC; Hung WC
    Cancer Res; 2003 Jun; 63(12):3069-72. PubMed ID: 12810630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines.
    Simizu S; Takagi S; Tamura Y; Osada H
    Cancer Res; 2005 Aug; 65(16):7455-61. PubMed ID: 16103099
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells.
    Liu LT; Chang HC; Chiang LC; Hung WC
    Oncogene; 2002 Nov; 21(54):8347-50. PubMed ID: 12447698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lycopene inhibits matrix metalloproteinase-9 expression and down-regulates the binding activity of nuclear factor-kappa B and stimulatory protein-1.
    Huang CS; Fan YE; Lin CY; Hu ML
    J Nutr Biochem; 2007 Jul; 18(7):449-56. PubMed ID: 17049831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Expression and significance of the matrix metalloproteinase inhibitor RECK gene in prostate cell strains].
    Xu ZY; Gao JP; Zhang ZP; Ge JP; Xu CL; Sun YH
    Zhonghua Nan Ke Xue; 2005 Oct; 11(10):727-30. PubMed ID: 16281502
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibitory effects of caffeic acid phenethyl ester on cancer cell metastasis mediated by the down-regulation of matrix metalloproteinase expression in human HT1080 fibrosarcoma cells.
    Hwang HJ; Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Lee SK
    J Nutr Biochem; 2006 May; 17(5):356-62. PubMed ID: 16214327
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Repression of matrix metalloproteinase gene expression by ginsenoside Rh2 in human astroglioma cells.
    Kim SY; Kim DH; Han SJ; Hyun JW; Kim HS
    Biochem Pharmacol; 2007 Dec; 74(11):1642-51. PubMed ID: 17880928
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effect of DA-125, a new anthracyclin analog antitumor agent, on the invasion of human fibrosarcoma cells by down-regulating the matrix metalloproteinases.
    Park HJ; Chung HJ; Min HY; Park EJ; Hong JY; Kim WB; Kim SH; Lee SK
    Biochem Pharmacol; 2005 Dec; 71(1-2):21-31. PubMed ID: 16271263
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dykellic acid inhibits phorbol myristate acetate-induced matrix metalloproteinase-9 expression by inhibiting nuclear factor kappa B transcriptional activity.
    Woo JH; Park JW; Lee SH; Kim YH; Lee IK; Gabrielson E; Lee SH; Lee HJ; Kho YH; Kwon TK
    Cancer Res; 2003 Jun; 63(12):3430-4. PubMed ID: 12810681
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
    Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
    J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of reversion-inducing cysteine-rich protein with Kazal motifs (RECK) indicates a shorter survival after resection in patients with adenocarcinoma of the lung.
    Takemoto N; Tada M; Hida Y; Asano T; Cheng S; Kuramae T; Hamada J; Miyamoto M; Kondo S; Moriuchi T
    Lung Cancer; 2007 Dec; 58(3):376-83. PubMed ID: 17714826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. RECK expression in osteosarcoma: correlation with matrix metalloproteinases activation and tumor invasiveness.
    Kang HG; Kim HS; Kim KJ; Oh JH; Lee MR; Seol SM; Han I
    J Orthop Res; 2007 May; 25(5):696-702. PubMed ID: 17262820
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Matrix metalloproteinase inhibitor reversion-inducing cysteine-rich protein with Kazal motifs: a prognostic marker for good clinical outcome in human breast carcinoma.
    Span PN; Sweep CG; Manders P; Beex LV; Leppert D; Lindberg RL
    Cancer; 2003 Jun; 97(11):2710-5. PubMed ID: 12767082
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wild-type p53 inhibits nuclear factor-kappaB-induced matrix metalloproteinase-9 promoter activation: implications for soft tissue sarcoma growth and metastasis.
    Liu J; Zhan M; Hannay JA; Das P; Bolshakov SV; Kotilingam D; Yu D; Lazar AF; Pollock RE; Lev D
    Mol Cancer Res; 2006 Nov; 4(11):803-10. PubMed ID: 17077165
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The interferon-stimulated gene factor 3 complex mediates the inhibitory effect of interferon-beta on matrix metalloproteinase-9 expression.
    Zhao X; Nozell S; Ma Z; Benveniste EN
    FEBS J; 2007 Dec; 274(24):6456-68. PubMed ID: 18028425
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Silencing of the metastasis suppressor RECK by RAS oncogene is mediated by DNA methyltransferase 3b-induced promoter methylation.
    Chang HC; Cho CY; Hung WC
    Cancer Res; 2006 Sep; 66(17):8413-20. PubMed ID: 16951151
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 1-furan-2-yl-3-pyridin-2-yl-propenone inhibits the invasion and migration of HT1080 human fibrosarcoma cells through the inhibition of proMMP-2 activation and down regulation of MMP-9 and MT1-MMP.
    Park BC; Thapa D; Lee YS; Kwak MK; Lee ES; Choi HG; Yong CS; Kim JA
    Eur J Pharmacol; 2007 Jul; 567(3):193-7. PubMed ID: 17507007
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vanillin inhibits matrix metalloproteinase-9 expression through down-regulation of nuclear factor-kappaB signaling pathway in human hepatocellular carcinoma cells.
    Liang JA; Wu SL; Lo HY; Hsiang CY; Ho TY
    Mol Pharmacol; 2009 Jan; 75(1):151-7. PubMed ID: 18835982
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.